It’s the interest rate, stupid. Home health, home care and hospice industry voices – including myself – have regularly pointed toward internal factors affecting M&A over the last two and a half years. In the end, the overarching, main headwind was always the extremely high interest rates that were put forth by the Federal Reserve […]
The home health sector offers an attractive investment opportunity, but also comes with challenges. It is poised to benefit from an aging population and the shift toward value-based care, however, it is also influenced by factors such as rising interest rates, reimbursement difficulties and staffing shortages, all of which have affected the M&A market. “I […]
There were at least 20 deals closed in home health, home care and hospice during the second quarter, in addition to a few major deals that were announced, but not finalized. Overall, recent months have shown a thaw in M&A may actually be in progress. The home health sector saw at least 10 deals, while […]
On April 23, the Federal Trade Commission (FTC) voted 3-2 to finalize a new rule largely prohibiting employers from enforcing non-competes against workers. While the regulatory timeline on the non-compete ban is fairly immediate, the rule will face intense legal pressure from a variety of groups, mainly of which will come from health care. Regardless […]
The home health, home care and hospice industries are barely exhibiting signs of life when it comes to M&A, sans a few active companies. Transactions were again historically low in the first quarter. Overall, only 12 total home-based care deals have been reported from the first quarter, according to data provided by the M&A firm […]
Thanks to impactful, large-scale transactions over the last decade, the collective face of home-based care has changed forever. Traditional providers in both home health care and personal home care have merged. Payers became involved in the home-based care space like never before. Of late, retailers have too. But it’s often easy to forget how the […]
A significant majority of buyers are planning to be more acquisitive in the home-based care space compared to 2023. However, the success in that endeavor hinges on three key factors: quality deal flow, capital markets and regulatory developments. That’s according to a new survey conducted by M&A advisory firm Mertz Taggart, which interviewed 51 of […]
Health care’s share of global private-equity (PE) deal count peaked at 13.7% in 2020. Three years later, that number fell to 10.8% — its lowest level since 2015. Compared to the bustling activity of 2021, home-based care dealmaking was mostly sluggish in 2023 and has followed that same trend. The slow year was largely due […]
Home-based care M&A volume finished strong in 2023, with dealmaking led by over a dozen non-medical home care transactions. The strong finish sets up 2024 to potentially be a more active year for buyers and sellers, assuming an improved macro-level economic outlook. Overall, the fourth quarter saw at least 25 transactions across all home-based care […]
In 2023, the decreasing influence of COVID-19 did not mitigate the overall operating pressures home health providers were forced to face. In the new year, there still remains plenty of opportunity, but much to work through to tap into that opportunity. More proposed rate cuts to home health reimbursement are expected from the Centers for […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
